Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
tositumomab low affinity immunoglobulin gamma fc region receptor ii-b biotech NA drugbank Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational unknown
tositumomab b-lymphocyte antigen cd20 biotech NA drugbank , DGIDB Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 45.97 approved,investigational antibody
tositumomab b-lymphocyte antigen cd20 biotech NA drugbank , DGIDB Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 45.97 approved,investigational antibody,inhibitor
tositumomab leukocyte surface antigen leu-16 NA Successful target TTD , DGIDB Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 45.97 approved antibody
tositumomab leukocyte surface antigen leu-16 NA Successful target TTD , DGIDB Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 45.97 approved inhibitor
tositumomab leukocyte surface antigen leu-16 NA Successful target TTD , DGIDB Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 45.97 approved unknown
click here to return to the previous page